Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients
about
Fulfilling the promise of personalized medicine? Systematic review and field synopsis of pharmacogenetic studiesGenetic testing for prevention of severe drug-induced skin rashHow drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusionThe anti-vaccination movement and resistance to allergen-immunotherapy: a guide for clinical allergistsPharmacovigilance training with focus on IndiaComorbidity and repeat admission to hospital for adverse drug reactions in older adults: retrospective cohort studyRole of regulatory agencies in translating pharmacogenetics to the clinicsThe future of pharmacologyWarfarin: almost 60 years old and still causing problemsPatient safety features of clinical computer systems: questionnaire survey of GP viewsPharmacogenetics, ethical issues: review of the Nuffield Council on Bioethics ReportMethods to reduce prescribing errors in elderly patients with multimorbidityHospitalization in older patients due to adverse drug reactions -the need for a prediction toolDrug Repurposing Is a New Opportunity for Developing Drugs against Neuropsychiatric DisordersNonproliferative and Proliferative Lesions of the Gastrointestinal Tract, Pancreas and Salivary Glands of the Rat and MouseCurrent research on pharmacologic and regenerative therapies for osteoarthritisPredicting risk of adverse drug reactions in older adultsRoutine deprescribing of chronic medications to combat polypharmacyValue of monitoring Nrf2 activity for the detection of chemical and oxidative stressNew genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivityEvolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response.Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomicsAdverse Drug Reaction Identification and Extraction in Social Media: A Scoping ReviewMonitoring medicines use: the role of the clinical pharmacologistUsing text-mining techniques in electronic patient records to identify ADRs from medicine usePredicting adverse drug reactions in older adults; a systematic review of the risk prediction modelsStem cell-derived hepatocytes as a predictive model for drug-induced liver injury: are we there yet?A systematic review of the emerging definition of 'deprescribing' with network analysis: implications for future research and clinical practiceA systematic review of observational studies evaluating costs of adverse drug reactionsThe Importance of Patient-Specific Factors for Hepatic Drug Response and ToxicitySeven steps to the diagnosis of NSAIDs hypersensitivity: how to apply a new classification in real practice?Natural Products for AntithrombosisEpidemiological modelling of routine use of low dose aspirin for the primary prevention of coronary heart disease and stroke in those aged > or =70Upper gastrointestinal haemorrhage associated with low-dose aspirin and anti-thrombotic drugs - a 6-year analysis and comparison with non-steroidal anti-inflammatory drugsThe established and emerging uses of aspirinAdverse drug reactions as cause of admission to hospital: only part of the picture was reported for aspirinAdverse drug reactions as cause of admission to hospital: admissions to ear, nose, and throat departments were not mentionedEvaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective studyClassification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugsScreening for dihydropyrimidine dehydrogenase deficiency: to do or not to do, that's the question
P2860
Q21091172-7BAAB150-D6E4-4F9A-9C80-EE48CEA89C1CQ24202114-B7315D31-BE55-4788-AF17-D2142129BD4FQ24273350-E808A4E4-DD35-466F-9A80-87F4688ADA23Q24595355-25A200A5-D8E8-4135-9986-0D1512B433D8Q24626045-810453B3-F664-49EB-BD0C-348EAC44112FQ24652604-60001AAA-D249-4148-BADF-9F6ADEF846BAQ24652693-A29ECBE9-4399-4E4A-9D30-50100911FAD6Q24670181-806A1C59-99A4-4000-867C-22332BDB8C0EQ24678632-D0528E66-A99E-43D1-8C98-7B7AE33FF4AEQ24679930-04D078C3-068C-4A10-A145-45604CF1D618Q24681986-B6221545-4D95-4004-89B3-DA20560B4009Q26744361-1DBAB40C-0C0C-46B4-9FF6-207684D0A4C1Q26748526-E616C7A7-F052-4EB8-B046-03D7A6CE4F9BQ26748728-9B2D3CB5-CF34-47D4-A352-D54EA9DC5479Q26766096-DC41CEC0-21F7-446E-B25A-4C0C07667AB1Q26766598-8E823C3D-CCDA-426C-9CD5-D46833B771B3Q26770379-DD094D4E-E7B0-4D84-B180-D960EBCB4D61Q26775802-17959438-1B4A-47E5-A728-3C8F2C80C1B9Q26778360-C23E4ADD-76EA-44A8-9FE9-6BEA2EE5384FQ26800976-089F9FE7-76B6-4493-A5A0-E46D1390FF8FQ26800980-C5845D02-9CC5-4D7F-8A6B-51CEBAD04AACQ26822796-B7324CFD-90D4-4BBD-B181-63E3E11EF8FCQ26824283-15E67DF1-F712-4308-973F-98B5F54B78BAQ26829859-94EF0CBE-EE3B-4A05-AC38-5AE4767E1A97Q26864161-F8581F40-40B6-40B9-BB78-17B9725045C1Q27006081-827F0F4A-98E8-4EAB-9471-E8C86639B90FQ27024267-90A39BE7-5D3E-4FC5-BD0F-194C5AD3C731Q28078344-BAF5CB74-1306-4854-ABE8-6AF1D24E1312Q28079380-6D5285CF-660A-42E7-B0D3-0CFB5F72955CQ28080256-BCC6C3F6-B368-406D-87EF-09949B080E4BQ28081823-016F8DEF-4B39-4065-AF38-B206BFFE1D4CQ28084934-0CAD4AF4-4814-444B-B4F0-49A7E4F90D4BQ28175859-A94C4367-0681-4AEA-ABF7-F76C92A4AEA6Q28186823-1EE06255-512E-4E89-92FC-91711EFC31E6Q28200673-F5E565AD-EAD0-412E-8AEB-C705691E8D64Q28211301-D44A5ADA-F460-4694-AB62-CC6C8F01356CQ28211311-56B81BCD-F798-4518-ABCE-61E7265A0E49Q28218980-49189D70-59D9-4D36-8952-B1DB3BB05191Q28300126-D7CB6AE2-DB76-461A-AB9E-FD5099CCCC1DQ28301967-75E21E1E-3F17-4428-8A1C-C2962F99CD19
P2860
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Adverse drug reactions as caus ...... ve analysis of 18 820 patients
@ast
Adverse drug reactions as caus ...... ve analysis of 18 820 patients
@en
Adverse drug reactions as caus ...... ve analysis of 18 820 patients
@nl
type
label
Adverse drug reactions as caus ...... ve analysis of 18 820 patients
@ast
Adverse drug reactions as caus ...... ve analysis of 18 820 patients
@en
Adverse drug reactions as caus ...... ve analysis of 18 820 patients
@nl
prefLabel
Adverse drug reactions as caus ...... ve analysis of 18 820 patients
@ast
Adverse drug reactions as caus ...... ve analysis of 18 820 patients
@en
Adverse drug reactions as caus ...... ve analysis of 18 820 patients
@nl
P2093
P2860
P3181
P356
P1433
P1476
Adverse drug reactions as caus ...... ve analysis of 18 820 patients
@en
P2093
Alasdair M Breckenridge
Andrew K Scott
B Kevin Park
Chris Green
Keith Farrar
Sally James
Shaun Meakin
Thomas J Walley
P2860
P3181
P356
10.1136/BMJ.329.7456.15
P407
P577
2004-07-03T00:00:00Z